Michael O’Donoghue

1.4k total citations
44 papers, 890 citations indexed

About

Michael O’Donoghue is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Education. According to data from OpenAlex, Michael O’Donoghue has authored 44 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 5 papers in Education. Recurrent topics in Michael O’Donoghue's work include Pharmacological Effects and Toxicity Studies (11 papers), Epilepsy research and treatment (10 papers) and Metabolism and Genetic Disorders (3 papers). Michael O’Donoghue is often cited by papers focused on Pharmacological Effects and Toxicity Studies (11 papers), Epilepsy research and treatment (10 papers) and Metabolism and Genetic Disorders (3 papers). Michael O’Donoghue collaborates with scholars based in United Kingdom, Australia and New Zealand. Michael O’Donoghue's co-authors include Josemir W. Sander, John S. Duncan, Keith Redhead, Michael D. Tharp, Donna Goodridge, Li M. Li, Alan Reid, Robert J. Mason, Ben Coomber and Glen B. Deacon and has published in prestigious journals such as The Lancet, Brain and Journal of Controlled Release.

In The Last Decade

Michael O’Donoghue

43 papers receiving 842 citations

Peers

Countries citing papers authored by Michael O’Donoghue

Since Specialization

Citations

This map shows the geographic impact of Michael O’Donoghue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael O’Donoghue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael O’Donoghue more than expected).

Fields of papers citing papers by Michael O’Donoghue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael O’Donoghue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael O’Donoghue. The network helps show where Michael O’Donoghue may publish in the future.

Co-authorship network of co-authors of Michael O’Donoghue

This figure shows the co-authorship network connecting the top 25 collaborators of Michael O’Donoghue. A scholar is included among the top collaborators of Michael O’Donoghue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael O’Donoghue. Michael O’Donoghue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom 2021 ·British Journal of Haematology ·(unknown), Nicolás Martínez‐Calle, Mark Bishton, Rocío Figueroa, (unknown), Michael O’Donoghue, Stuart Smith, Paul Byrne, Simon Paine, (unknown), Dorothee P. Auer, Eleanor James, E.M. Bessell, Matthew J. Grainge, Christopher P. Fox	7
2	Adjunctive use of the ketogenic diet in a young adult with UBE2A deficiency syndrome and super-refractory status epilepticus 2021 ·Epilepsy & Behavior Reports ·Christopher Allen, (unknown), (unknown), (unknown), (unknown), Michael O’Donoghue	1
3	MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity 2019 ·Journal of Neurology ·Αθανάσιος Παπαθανασίου, Radu Tănăsescu, (unknown), (unknown), (unknown), Michael O’Donoghue, Cris S. Constantinescu	23
4	Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy 2018 ·Seizure ·(unknown), (unknown), (unknown), Michael O’Donoghue, (unknown), William Whitehouse	22
5	Optic ataxia and the dorsal visual steam re-visited: Impairment in bimanual haptic matching performed without vision 2017 ·Cortex ·Stephen R. Jackson, Laura Condon, Roger Newport, Sally Pears, Masud Husain, Nin Bajaj, Michael O’Donoghue	3
6	Producing Video For Teaching and Learning: Planning and Collaboration 2013 ·Michael O’Donoghue	3
7	Developing a hierarchy of clicker use for teaching and learning from models of dialogue analysis 2010 ·EdMedia: World Conference on Educational Media and Technology ·Michael O’Donoghue, R. J. Jardine, (unknown)	4
8	The safety of anti-epileptic drug regimens: a qualitative study of factors determining the success of counselling women before conception 2009 ·Journal of Family Planning and Reproductive Health Care ·(unknown), Michael O’Donoghue	17
9	A historical perspective on the mortality associated with chronic epilepsy 2009 ·Acta Neurologica Scandinavica ·Michael O’Donoghue, Josemir W. Sander	9
10	There may be more to reaching than meets the eye: Re-thinking optic ataxia 2009 ·Neuropsychologia ·Stephen R. Jackson, Roger Newport, Masud Husain, (unknown), Michael O’Donoghue, Nin Bajaj	40
11	Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid 2008 ·Synapse ·Ben Coomber, Michael O’Donoghue, Robert J. Mason	34
12	Creutzfeldt-Jakob Disease, Prion Protein Gene Codon 129VV, and a Novel PrPSc Type in a Young British Woman 2007 ·Archives of Neurology ·Simon Mead, Susan Joiner, Melanie Desbruslais, Jonathan Beck, Michael O’Donoghue, P. L. Lantos, Jonathan D. F. Wadsworth, John Collinge	18
13	Antihistamines and their role as antipruritics 2005 ·Dermatologic Therapy ·Michael O’Donoghue, Michael D. Tharp	53
14	The subjective handicap of epilepsy. A new approach to measuring treatment outcome 1998 ·Brain ·Michael O’Donoghue	65
15	Sustained-release delivery systems and their application for endoparasite control in animals 1998 ·Journal of Controlled Release ·Michael Cardamone, (unknown), (unknown), (unknown), Michael O’Donoghue, Shari A. Lofthouse, M R Brandon	2
16	The National Hospital Seizure Severity Scale: A Further Development of the Chalfont Seizure Severity Scale 1996 ·Epilepsia ·Michael O’Donoghue, John S. Duncan, Josemir W. Sander	171
17	Does Early Anti-Epileptic Drug Treatment Alter the Prognosis for Remission of the Epilepsies? 1996 ·Journal of the Royal Society of Medicine ·Michael O’Donoghue, Josemir W. Sander	8
18	Myoclonic epilepsy of late onset in trisomy 21 1995 ·Arquivos de Neuro-Psiquiatria ·Li M. Li, Michael O’Donoghue, Josemir W. Sander	20
19	Lamotrigine versus carbamazepine in epilepsy 1995 ·The Lancet ·Michael O’Donoghue, Josemir W. Sander, Orvar Eeg‐Olofsson, E. H. Reynolds, M.J. Brodie, Alan Richens, (unknown), (unknown), O. Chosidow, Franck Semah, Dan Lipsker, Camille Françès, S. Herson, (unknown), (unknown), (unknown)	15
20	A guide to man-made gemstones 1983 ·Medical Entomology and Zoology ·Michael O’Donoghue	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact